These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23870612)

  • 21. Quetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway.
    Wang HN; Liu GH; Zhang RG; Xue F; Wu D; Chen YC; Peng Y; Peng ZW; Tan QR
    Int J Neuropsychopharmacol; 2015 Aug; 19(2):. PubMed ID: 26232790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
    Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
    J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
    Metzger-Peter K; Kremer LD; Edan G; Loureiro De Sousa P; Lamy J; Bagnard D; Mensah-Nyagan AG; Tricard T; Mathey G; Debouverie M; Berger E; Kerbrat A; Meyer N; De Seze J; Collongues N
    Trials; 2020 Jun; 21(1):591. PubMed ID: 32600454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
    Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
    J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis.
    Titus HE; Chen Y; Podojil JR; Robinson AP; Balabanov R; Popko B; Miller SD
    Front Cell Neurosci; 2020; 14():599717. PubMed ID: 33192332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
    Zhornitsky S; Potvin S; Moteshafi H; Dubreucq S; Rompré PP; Stip E
    Int Clin Psychopharmacol; 2011 Jul; 26(4):183-92. PubMed ID: 21372722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of quetiapine in the treatment of bipolar disorder.
    Pini S; Abelli M; Cassano GB
    Expert Opin Pharmacother; 2006 May; 7(7):929-40. PubMed ID: 16634715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remyelination therapy for multiple sclerosis.
    Keough MB; Yong VW
    Neurotherapeutics; 2013 Jan; 10(1):44-54. PubMed ID: 23070731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.
    Xiao L; Xu H; Zhang Y; Wei Z; He J; Jiang W; Li X; Dyck LE; Devon RM; Deng Y; Li XM
    Mol Psychiatry; 2008 Jul; 13(7):697-708. PubMed ID: 17684494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoting myelin repair and return of function in multiple sclerosis.
    Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
    FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report.
    Mancini-Marïe A; Fahim C; Potvin S; Beauregard M; Stip E
    Eur Psychiatry; 2006 Dec; 21(8):574-7. PubMed ID: 16140509
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeting oligodendrocyte protection and remyelination in multiple sclerosis.
    Zhang J; Kramer EG; Mahase S; Dutta DJ; Bonnamain V; Argaw AT; John GR
    Mt Sinai J Med; 2011; 78(2):244-57. PubMed ID: 21425268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG; Voda J; Yu X; McKeon G; Bourdette DN
    J Neurosci Res; 2004 Aug; 77(3):367-77. PubMed ID: 15248293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
    Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
    FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia.
    J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice.
    Tempier A; He J; Zhu S; Zhang R; Kong L; Tan Q; Luo H; Kong J; Li XM
    Curr Alzheimer Res; 2013 Feb; 10(2):199-206. PubMed ID: 22950914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.